Pioglitazone enhances mitochondrial biogenesis and ribosomal protein biosynthesis in skeletal muscle in polycystic ovary syndrome.
Insulin resistance is a common metabolic abnormality in women with PCOS and leads to an elevated risk of type 2 diabetes. Studies have shown that thiazolidinediones (TZDs) improve metabolic disturbances in PCOS patients. We hypothesized that the effect of TZDs in PCOS is, in part, mediated by change...
Enregistré dans:
Auteurs principaux: | Vibe Skov, Dorte Glintborg, Steen Knudsen, Qihua Tan, Thomas Jensen, Torben A Kruse, Henning Beck-Nielsen, Kurt Højlund |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2008
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/91a52f2354ba4d80ab0891b2d6f27951 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Genetic alterations within the DENND1A gene in patients with polycystic ovary syndrome (PCOS).
par: Mette B Eriksen, et autres
Publié: (2013) -
Metabolomics reveals reduction of metabolic oxidation in women with polycystic ovary syndrome after pioglitazone-flutamide-metformin polytherapy.
par: Maria Vinaixa, et autres
Publié: (2011) -
Structural basis of GTPase-mediated mitochondrial ribosome biogenesis and recycling
par: Hauke S. Hillen, et autres
Publié: (2021) -
Chemerin regulates autophagy to participate in polycystic ovary syndrome
par: Xiaodong Luo, et autres
Publié: (2021) -
Endometrial markers of polycystic ovary syndrome (literature review)
par: E. M. Sharifulin, et autres
Publié: (2017)